MIR4782

Across TCGA pan-cancer cohorts, MIR4782 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR4782’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where MIR4782 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4782 is over-expressed in tumor, although a few such as THCA and BLCA show the opposite, repressed pattern.

KIRP, THCA, and CHOL are the cancer types where MIR4782 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4782 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Male	III,IV	+0.673	.001	5	view →
THCA	Female	All	−0.449	<.001	5	view →
CHOL	All	All	+0.655	.026	2	view →
BLCA	Male	All	+0.614	.031	2	view →
BLCA	Female	IV	−0.636	.010	1	view →
KICH	All	All	−0.260	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 5 lineages.

MIR4782–KIRP

Open the KIRP breakdown →